No abstract available
Keywords:
JAK inhibitor; TYK2; cutaneous lupus erythematosus; evidence-based; systematic review; therapeutics; treatment.
MeSH terms
-
Humans
-
Janus Kinase Inhibitors* / therapeutic use
-
Janus Kinases
-
Lupus Erythematosus, Cutaneous* / drug therapy
-
Lupus Erythematosus, Systemic* / drug therapy
-
Molecular Targeted Therapy
Substances
-
Janus Kinase Inhibitors
-
Janus Kinases